Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tamami Yano is active.

Publication


Featured researches published by Tamami Yano.


Pediatric Neurology | 2000

Progressive facial hemiatrophy after epileptic seizures.

Tamami Yano; Yukio Sawaishi; Miyuki Toyono; Iwao Takaku; Goro Takada

Intractable complex partial seizures developed in a 3-year-old female with normal intracranial findings on computed tomography. Frontal paramedian band-like depression of the skin gradually developed thereafter, and progressive facial hemiatrophy (Parry-Romberg syndrome) was diagnosed. Computed tomography scanning at 5 years of age revealed multiple parenchymal calcifications and low-density areas in the white matter of the frontoparietal lobes. Epileptic seizures, one of the major neurologic complications of progressive facial hemiatrophy, could precede the succeeding neurocutaneous changes.


Pediatric Neurology | 1999

SSPE following neonatal measles infection.

Yukio Sawaishi; Tamaki Abe; Tamami Yano; Kohsei Ishikawa; Goro Takada

The authors report a case of subacute sclerosing panencephalitis in a child who had measles during the neonatal period. At 3 years, 6 months of age, over a period of a few weeks, the patient lost the ability to sit unaided as a result of progressive truncal ataxia, without apparent cognitive changes, simulating acute cerebellar ataxia. His symptoms improved in 1 month, and he was able to walk again with support, but mental alteration and periodic mild head nodding on awakening followed. His illness was diagnosed as subacute sclerosing panencephalitis on the basis of the elevated titers of measles antibodies in the cerebrospinal fluid. Measles infection before 1 year of age is a risk factor of subacute sclerosing panencephalitis, but reports about patients with neonatal measles infection are rare. Immaturity of the brain at the time of measles infection may not only be a risk factor but may also influence the clinical course of the disease.


Neurology | 2002

Juvenile Alexander disease with a novel mutation in glial fibrillary acidic protein gene

Yukio Sawaishi; Tamami Yano; Iwao Takaku; Goro Takada

Early-onset (infantile) Alexander disease is associated with mutations in the glial fibrillary acidic protein (GFAP) gene and two hot spots correlate to the severe phenotype. No molecular mechanisms have been elucidated in late-onset (juvenile) Alexander disease. The authors report a novel GFAP mutation in a patient with juvenile Alexander disease. The authors discuss similar molecular mechanisms in another intermediate filament disease and propose a possible molecular pathogenesis in juvenile Alexander disease.


Brain & Development | 2010

Nationwide survey (incidence, clinical course, prognosis) of Rasmussen’s encephalitis

Ayako Muto; Hirokazu Oguni; Yukitoshi Takahashi; Yukiyoshi Shirasaka; Yukio Sawaishi; Tamami Yano; Toru Hoshida; Hitoshi Osaka; Satoru Nakasu; Noriyuki Akasaka; Kenji Sugai; Akie Miyamoto; Satoru Takahashi; Motomasa Suzuki; Iori Ohmori; Shin Nabatame; Makiko Osawa

PURPOSE Rasmussens encephalitis (RE) is a progressive and catastrophic epileptic disorder caused by chronic localized encephalitis. We performed a nationwide survey of RE to assess the clinical picture, treatment effect, and prognosis of Japanese RE patients. SUBJECTS & METHODS The subjects were 27 patients (male:12; female:15) from 13 medical facilities. All of them satisfied the clinical and neuroimaging criteria for RE, including 14 pathologically proven cases. RESULTS They were divided into the childhood-onset rapidly progressive type (CORP, n=19), and late-onset slowly progressive type (LOSP, n=8). The mean age at epilepsy onset was 4 years and 4 months in CORP, and 16 years in LOSP. The mean period between the onset age of epilepsy and development of frequent seizures was 1 year and 4 months in the former, and 3 years and 4 months in the latter. The immunomodulatory treatment including high-dose steroid (n=14) and high-dose intravenous immunoglobulin therapies (IVIgG, n=12) achieved more than a 50% reduction in the seizure frequency in 5 (36%) and 4 (33%) patients, respectively. Eight and seven patients underwent focal cortical resection and functional hemispherectomy, leading to significant improvement in 5 of the 8 patients and excellent seizure control in all 7 patients, respectively. CONCLUSION Although the high-dose steroid and IVIG therapies may have alleviated the exacerbation of seizures in those with RE, they could not halt the disease progression. Functional hemispherectomy is still the only curative therapy for RE, despite the fact that the early introduction of this procedure remains controversial.


Journal of the Neurological Sciences | 1999

Migratory basal ganglia lesions in subacute sclerosing panencephalitis (SSPE): Clinical implications of axonal spread

Yukio Sawaishi; Tamami Yano; Yasuhiro Watanabe; Goro Takada

We report a boy with subacute sclerosing panencephalitis (SSPE) who exhibited parkinsonian symptoms four months after onset. The symptoms improved after administration of levodopa. One year after onset, bilateral symmetric lesions appeared in the substantia nigra and the putamen, as observed using magnetic resonance imaging. After a one-year interval, the lesions migrated to the bilateral caudate and the cerebellar dentate nuclei. The series of migratory legions, each of which was connected by axonal pathways originating from the substantia nigra, suggests axonal spread of the SSPE virus.


Epilepsia | 2002

Lidocaine-dependent Early Infantile Status Epilepticus with Highly Suppressed EEG

Yukio Sawaishi; Tamami Yano; Masamichi Enoki; Goro Takada

Summary: We report an early infantile patient characterized by intractable hyponatremia, progressive megalencephaly, and epileptic seizures with an EEG pattern that alternated between interictal low‐voltage background and ictal burst activity. Repeatedly all the abnormal findings improved in a lidocaine‐dependent manner. Given the pharmacologic mechanisms of lidocaine as a sodium channel blocker, we speculate that our patient had a sodium channel dysfunction.


Journal of the Neurological Sciences | 1999

Positron emission tomography in juvenile Alexander disease

Yukio Sawaishi; Jun Hatazawa; Nobuhiko Ochi; Hiyoshi Hirono; Tamami Yano; Yasuhiro Watanabe; Toshio Okudera; Goro Takada

A 13-year-old boy with cervical kyphosis was diagnosed as having juvenile Alexander disease because of the typical MRI findings, abnormally elevated alphaB-crystallin and heat shock protein 27 in the cerebrospinal fluid. Positron emission tomography with 18F-fluorodeoxyglucose demonstrated hypometabolism in the frontal white matter corresponding to the areas with leukodystrophy. However, the overlying gray matter preserved normal glucose metabolism.


Journal of Neuro-oncology | 2003

Choroid Plexus Carcinoma Presented with Spinal Dysfunction Caused by a Drop Metastasis: A Case Report

Yukio Sawaishi; Tamami Yano; Yasuji Yoshida; Yasunobu Ito; Kazuo Mizoi; Aya Hirayama; Iwao Takaku; Goro Takada

A 2-year-old girl demonstrating gait disturbance and dysuria was evaluated and showed two large remote tumors at the left lateral ventricle and lower spinal canal. Pathological analysis demonstrated both of the tumors to be choroid plexus carcinoma (CPC) with high MIB-1 labeling index. The enhanced mitotic propensity would have contributed to an early stage of drop metastasis from the primary site to the sacral sac and following accelerated formation of a longitudinal tumor, which had grown in the subarachnoid space conforming to the spinal canal and finally caused the presenting symptoms of spinal dysfunction. This report shows that CPC can develop exophytically in the subarachnoid space as well as in the ventricle simultaneously before appearance of clinical symptoms and confirms the importance of extensive neuroimaging in its evaluation.


Brain & Development | 2016

Loss-of-function mutations of STXBP1 in patients with epileptic encephalopathy

Toshiyuki Yamamoto; Keiko Shimojima; Tamami Yano; Yuki Ueda; Rumiko Takayama; Hiroko Ikeda; Katsumi Imai

Epileptic encephalopathy, which commences during early infancy, is a severe epileptic syndrome that manifests as age-dependent seizures and severe developmental delay. The syntaxin-binding protein 1 gene (STXBP1) is one of the genes responsible for epileptic encephalopathy. We conducted a cohort study to analyze STXBP1 in 42 patients with epileptic encephalopathy. We identified four novel mutations: two splicing mutations, a frameshift mutation, and a nonsense mutation. All of these mutations were predicted to cause loss-of-function. This result suggests loss-of-function is a common mechanism underlying STXBP1-related epileptic encephalopathy. The four patients showed epileptic features consistent with STXBP1-related epileptic encephalopathy, but showed variable radiological findings, including brain volume loss and myelination delay.


Epilepsia | 2000

Lidocaine‐Dependent Early Infantile Epileptic Encephalopathy with Hyponatremia and Highly Suppressed EEG

Yukio Sawaishi; Tamami Yano; Masamichi Enoki; Goro Takada

Purpose: Early infantile epileptic encephaiopathy with suppression burst (EIEE) is characterized by an EEG pattern that alternates between an irregular mixture of spikes and waves and almost flat activity, each lasting from 1 to several seconds. This report presents a case characterized by lidocaine dependence, intractable hyponatremia, and an EEG pattern that alternates between extremely long suppression and short burst. In addition, the possible pathomechanism of the suppression is discussed.

Collaboration


Dive into the Tamami Yano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge